Skip to main content
. 2021 Sep 14;15:1289. doi: 10.3332/ecancer.2021.1289

Table 1. Amount of blood products transfusing to Peruvian patients with gastrointestinal cancer (n = 163).

Type of cancer Blood products Total
RBCC PQ FFP CRYO
Gastric (n = 6)a 9 (3) 2 (0.7) 4 (1.3) c 15 (4.9)
Pancreas (n = 54) 75 (24.7) 1 (0.3) 4 (1.3) 80 (26.3)
Liver (n = 16)b 22 (7.2) 2 (0.7) 9 (3) 33 (10.9)
Gallbladder (n = 6) 5 (1.6) 2 (0.7) 7 (2.3)
Gut (n = 7) 9 (3) 2 (0.7) 4 (1.3) 15 (4.9)
Colon (n = 68) 121 (39.8) 4 (1.3) 2 (0.7) 127 (41.8)
Anus (n = 4) 6 (2) 1 (0.3) 7 (2.3)
Oesophagus (n = 2) 20 (6.6) 20 (6.6)
Total 247 (81.3) 11 (3.6) 26 (8.6) 20 (6.6) 304 (100)
a

Four units of RBCC and four units of FFP were transfused in one patient

b

Three units of RBCC and one unit of FFP were transfused in a patient

c

Not transfusedRBCC, Red blood cell concentrate; PQ, Platelets; FFP, Fresh frozen plasma; CRYO, Cryoprecipitate